Back

The effectiveness of eplerenone vs spironolactone on left ventricular systolic function, hospitalization and cardiovascular death in patients with chronic heart failure - HFrEF

27 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Clinical heart failure from diagnostics to treatment Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Nabil Naser

Polyclinic Dr. Nabil - Faculty of Medicine University of Sarajevo, Sarajevo (Bosnia and Herzegovina)

6 More presentations in this session

Presentation thumbnail
Real-world drug prescription patterns and mortality risk in patients hospitalized with acute heart hailure: impact of multimorbidity and heart failure phenotype
Professor C. Angermann (Wurzburg, DE)
Abstract Slides Video
Presentation thumbnail
Heart rate reduction and outcomes in heart failure outpatients
Doctor F. Memenga (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Similar heart failure hospitalization and survival benefits are associated with Sacubitril/Valsartan therapy in CRT non responders and in HFrEF patients with no CRT indication
Doctor K. Szabo (Debrecen, HU)
Abstract Slides Video
Presentation thumbnail
Impact of the role of cardiology pharmacy specialist on the improvement of quality indicators among patients with heart failure and reduced ejection fraction
Professor H. Al Farhan (Baghdad, IQ)
Abstract Slides Video
Presentation thumbnail
The effect of long-term application of guideline-directed medical therapy on systolic blood pressure in hospitalized patients with heart failure with reduced ejection fraction
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical heart failure from diagnostics to treatment

The Event

Event poster

ESC Congress 2023

27 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Mineralocorticoid receptor antagonist therapy in patients with ischemic heart failure and ventricular tachycardia: a comparative analysis of spironolactone vs. eplerenone
thumbnail
Congress Presentation
MRAs in heart failure - An individual patient data meta-analysis of randomised trials
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources